Cargando…
miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel
Breast cancer remains the most commonly diagnosed cancer in Chinese women. Paclitaxel (PTX) is a chemotherapy medication used to treat breast cancer patients. However, a side effect of paclitaxel is the severe drug resistance. Previous studies demonstrated that dysregulation of microRNAs could regul...
Autores principales: | Ma, Changpo, Shi, Xuejun, Guo, Wenchao, Niu, Jianxin, Wang, Guangshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555243/ https://www.ncbi.nlm.nih.gov/pubmed/31206033 http://dx.doi.org/10.1515/med-2019-0049 |
Ejemplares similares
-
miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation
por: Ma, Changpo, et al.
Publicado: (2019) -
Effects of MiR-107 on The Chemo-drug Sensitivity of Breast Cancer Cells
por: Luo, Yong, et al.
Publicado: (2019) -
Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
por: Chen, Yongyi, et al.
Publicado: (2020) -
Erratum to metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
por: Chen, Yongyi, et al.
Publicado: (2020) -
Pleiotropic functions of miR107 in cancer networks
por: Luo, Zhiying, et al.
Publicado: (2018)